Sector valuations NovoCure Limited
Equities
NVCR
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.43 USD | -3.45% | -9.86% | -12.25% |
Dec. 02 | HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating | MT |
Dec. 02 | NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint | MT |
P/E ratio (Y) | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
-20.91x | - | 0.64x | 4.66x | -19.47x | -18.46x | - | 2.96B | ||
576.17x | 8.468 | -7.07x | 7.7x | 59.35x | 68.65x | -.--% | 9.48B | ||
95x | - | 6.16x | 3.29x | 17.76x | 20.68x | - | 8.86B | ||
16.49x | 2.602 | -1.18x | - | - | - | +1.72% | 4.67B | ||
-66.85x | 10.34 | -0.02x | 7.59x | -118.86x | -80.94x | -.--% | 4.64B | ||
24.87x | 1.635 | -1.65x | 1.78x | 10.46x | 15.6x | +2.37% | 4.52B | ||
46.78x | 13.92 | 1.55x | - | - | - | +0.55% | 4.46B | ||
35.11x | 4.223 | 1.49x | 5.48x | 17.97x | 23.95x | +0.95% | 4.35B | ||
42.78x | 2.327 | 0.44x | - | - | - | +0.51% | 1.27B | ||
21.05x | 3.141 | 0.99x | - | - | - | - | 1.23B | ||
50.38x | 13.47 | 1.7x | 17.78x | 34.44x | 37.92x | +0.72% | 1.22B | ||
-9.02x | 1.920 | -0.97x | 433.29x | -37.22x | -36.61x | -.--% | 969M | ||
-20.71x | 4.099 | 0.68x | 3.48x | -95.08x | -15.56x | -.--% | 681M | ||
81.79x | 2.533 | -2.33x | - | - | - | - | 665M | ||
-9.02x | 4.443 | -0.62x | 2.34x | -37.18x | -8.39x | -.--% | 521M | ||
39.04x | - | -0.8x | - | - | - | - | 488M | ||
28.2x | - | -0.56x | - | - | - | - | 413M | ||
-12.59x | - | 0.14x | 1.26x | 9.6x | 24.41x | - | 376M | ||
Average | 51.03x | 5.62 | -0.08x | 44.42x | -14.38x | 2.84x | +0.62% | 2.88B | |
Weighted average by Cap. | 128.91x | 6.73 | -0.18x | 16.29x | 4.17x | 15.11x | +0.73% |
- Stock Market
- Equities
- NVCR Stock
- Sector NovoCure Limited
- Sector valuations